
Physiogenex
Escalquens, France physiogenex.com From their website, Nov 2026
Work here? Claim this listing
About
Physiogenex is a preclinical CRO based near Toulouse, France, focused on metabolic disorders. It provides in vivo, ex vivo, and in vitro studies for pharmaceutical, biotechnology, nutraceutical, and agri-food companies working on obesity, diabetes, MASH, fibrosis, diabetic nephropathy, dyslipidemia, atherosclerosis, and related complications.
Services
Preclinical drug development
Provides predictive rodent models and radio-tracer-based technologies to generate proof-of-concept efficacy data for drugs targeting metabolic diseases.
ADME, DMPK & toxicology
Post launched studies
Helps investigate the mechanisms by which a drug shows clinical benefits or side effects using animal models reflecting the human context.
ADME, DMPK & toxicology
Consulting
Supports project planning and preclinical drug development program setup and follow-up for metabolic disease programs.
In vivo metabolic studies
Runs in vivo efficacy, phenotyping, tolerance, clamp, metabolism, imaging, and tissue collection studies in metabolic disease models.
ADME, DMPK & toxicology
Ex vivo metabolic assays
Performs ex vivo assays on muscles and adipocytes, including glucose uptake, free fatty acid oxidation, and lipolysis.
In vitro assays
Offers cell-based and spheroid assays using adipocytes, muscle cells, hepatocytes, HepaRG, and 3D liver models for obesity, diabetes, and MASH/MASH-related research.
Biochemical assays and histology analysis
Measures hormones, cytokines, lipids, gene and protein expression, and performs histology, immunohistology, and histopathological scoring.
Biological samples library
Maintains a biological samples library for study support.
- Turnaround
- 1 to 8 weeks
- What to send
- Animals already on diet are available for some MASH models
Capabilities
- Assays and studies
- In vivo
- Rodent models
- Biochemical assays
- Histopathology
- Lipolysis
- Glucose uptake
13 more
- Glucose tolerance test
- Insulin tolerance test
- Hyperinsulinemic-euglycemic clamp
- Hyperglycemic clamp
- Lipid tolerance test
- Lipogenesis
- Body composition
- Indirect calorimetry
- Echocardiography
- Plasma cytokines
- qPCR
- Histology
- Immunohistology
- Scale and capacity
- 5000m² site
- 1010m² building surface area
- Animal housing with quarantine area and SPF area
- Therapeutic areas
- Obesity
- Insulin resistance
- Type 2 diabetes
- MASH
- MetALD
- Fibrosis
9 more
- Diabetic nephropathy
- Chronic kidney disease
- Cardiovascular complications
- Dyslipidemia
- Atherosclerosis
- Inflammation
- Immunometabolism
- Nutraceuticals
- Covid-19
Instruments and platforms
- Phenomaster
- Echo MRI
- Minispec
- Medibeacon devices
- FITC-sinistrin
Modalities and species
- Modalities
- Small molecule
- Recombinant protein
- Species and models
- Human adipocytes
- Rodent adipocytes
- Mouse
- Rat
- Hamster
- HepaRG
9 more
- Human hepatocytes
- Kupffer cells
- Stellate cells
- Db/db mouse
- Ob/ob mouse
- Zucker diabetic fatty rat
- Zucker fatty rat
- Goto-Kakizaki rat
- Streptozotocin rat
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Company
- Type
- CRO
- Founded
- 2003
- Quality
- Research Tax Credits Accredited CRO
Locations
- Based in
- Escalquens, France
- Sites
- Toulouse, France
- Serves
- Worldwide